Stephane Bancel - Net Worth and Insider Trading

Stephane Bancel Net Worth

The estimated net worth of Stephane Bancel is at least $1.3 Billion dollars as of 2026-07-21. Stephane Bancel is the CEO of Moderna Inc and owns about 21,269,463 shares of Moderna Inc (MRNA) stock worth over $1.3 Billion. Details can be seen in Stephane Bancel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephane Bancel has not made any transactions after 2025-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Stephane Bancel

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Stephane Bancel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephane Bancel owns 4 companies in total, including Moderna Inc (MRNA) , Syros Pharmaceuticals Inc (SYRS) , and BG Medicine Inc (BGMD) among others .

Click here to see the complete history of Stephane Bancel’s form 4 insider trades.

Insider Ownership Summary of Stephane Bancel

Ticker Company Transaction Date Type of Owner
MRNA Moderna Inc 2025-03-03 director & Chief Executive Officer
SYRS Syros Pharmaceuticals Inc 2016-06-29 director
BGMD BG Medicine Inc 2014-06-03 director
LIMIT LIMIT 2026-02-26 director

Stephane Bancel Latest Holdings Summary

Stephane Bancel currently owns a total of 1 stock. Stephane Bancel owns 21,269,463 shares of Moderna Inc (MRNA) as of March 3, 2025, with a value of $1.3 Billion.

Latest Holdings of Stephane Bancel

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRNA Moderna Inc 2025-03-03 21,269,463 59.49 1,265,320,354

Holding Weightings of Stephane Bancel


Stephane Bancel Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephane Bancel has made a total of 104 transactions in Moderna Inc (MRNA) over the past 5 years, including 1 buys and 103 sells. The most-recent trade in Moderna Inc is the acquisition of 160,314 shares on March 3, 2025, which cost Stephane Bancel around $5 Million.

Insider Trading History of Stephane Bancel

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephane Bancel Trading Performance

GuruFocus tracks the stock performance after each of Stephane Bancel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephane Bancel is -8.13%. GuruFocus also compares Stephane Bancel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephane Bancel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephane Bancel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephane Bancel

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.25 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Stephane Bancel owns.
View MRNA Analysis

Stephane Bancel Ownership Network

Ownership Network List of Stephane Bancel

No Data

Ownership Network Relation of Stephane Bancel

Insider Network Chart


Stephane Bancel Owned Company Details

What does Moderna Inc do?

Who are the key executives at Moderna Inc?

Stephane Bancel is the director & Chief Executive Officer of Moderna Inc. Other key executives at Moderna Inc include President Stephen Hoge , Chief Commercial Officer Soria Ester Banque , and Chief Legal Officer Shannon Thyme Klinger .

Moderna Inc (MRNA) Insider Trades Summary

Over the past 18 months, Stephane Bancel made 1 insider transaction in Moderna Inc (MRNA) with a net purchase of 160,314. Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 320,017 shares made by Stephen Hoge , a net sale of 6,498 shares made by Abbas Hussain , and a net sale of 33,116 shares made by Noubar Afeyan .

In summary, during the past 3 months, insiders sold 178,424 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 178,424 shares. During the past 18 months, 376,987 shares of Moderna Inc (MRNA) were sold and 160,314 shares were bought by its insiders, resulting in a net sale of 216,673 shares.

Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Moderna Inc Insider Transactions

No Available Data

Stephane Bancel Mailing Address

Above is the net worth, insider trading, and ownership report for Stephane Bancel. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stephane Bancel's mailing address is: Cambridge Ma 02142.